Shamburg News · 8-K filed Nov 2, 2026, 4:33 PM EST
Chemours Reports Third Quarter 2026 Net Income of $196 Million, or $1.29 Per Diluted Share
CC · Chemours Co
- Earnings
- Materiality: high
The Chemours Company reported third quarter 2026 net income attributable to Chemours of $196 million, or $1.29 per diluted share, compared with $46 million, or $0.31 per diluted share, a year earlier. Adjusted net income was $31 million, or $0.21 per diluted share, and adjusted EBITDA was $200 million, compared with $189 million in the prior-year quarter. The company furnished the results in a press release dated November 2, 2026, and expects fourth quarter 2026 adjusted EBITDA between $160 million and $185 million, with full-year 2026 adjusted EBITDA between $775 million and $800 million.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001627223-26-000032.
Written from the filing by Shamburg Markets. Figures are as reported by the company.